Table 3.
Subgroups | Studies, n | Prevalence (%) | 95% CI | Heterogeneity across the studies | Heterogeneity between groups (P-value) |
|
---|---|---|---|---|---|---|
I2 | P-value | |||||
Gender | ||||||
Female | 5 | 32.15 | 21.53–45.01 | 89.68 | < 0.001 | 0.431 |
Male | 5 | 25.07 | 14.61–39.56 | 90.09 | < 0.001 | |
Quality of studies | ||||||
High | 5 | 24.27 | 14.54–37.65 | 97.07 | < 0.001 | 0.630 |
Fair | 5 | 28.14 | 87.06 | < 0.001 | ||
Tools used | ||||||
BDI | 2 | 30.64 | 24.94–37.01 | 52.82 | 0.145 | 0.526 |
CDI | 3 | 22.13 | 9.91–42.34 | 94.84 | < 0.001 | |
CES-D | 2 | 35.04 | 18.00–57.00 | 95.26 | < 0.001 | |
Others | 3 | 21.64 | 11.46–37.07 | 92.58 | < 0.001 | |
Age group | ||||||
10–14 | 3 | 29.82 | 20.06–42.83 | 56.75 | 0.099 | 0.414 |
15–19 | 5 | 37.09 | 24.72–51.43 | 91.75 | < 0.001 |